← Leaderboards
Carlos Fernandez Hernando
Yale University
$14,750,691
Attributed
$14,981,003
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2011–25$2M$1.5M$1M$500K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,981,003 · 7
By mechanism
R01$8,569,965 · 5
R35$5,950,413 · 1
R21$460,625 · 1
Top collaborators
- Daniel Greif2 shared
Most similar at Yale University
Same institution · by research overlap
- Kathleen Ann Martin$14,895,788
- Adam H. De Havenon$5,725,083
- Hooman Kamel$18,001,522
- Arindam R. Chatterjee$820,493
- Daniel Jovin$37,522
Others in their field
Top investigators on “Lipids”
- Constance Ann Benson · University Of California, San Diego$84,289,569
- Alan M Fogelman · University Of California Los Angeles$57,458,120
- Paul M. Ridker · Brigham And Women'S Hospital$56,179,451
- Adrian Hernandez · Duke University$50,769,596
- Garret A Fitzgerald · University Of Pennsylvania$50,340,498
- Richard A Gibbs · Baylor College Of Medicine$49,140,324
Research focus
LipidsMolecularAtherosclerosisInsightCholesterolGeneticIn VivoCholesterol HomeostasisLipoproteinsCellsLipid MetabolismBiogenesisHigh Density LipoproteinsMetabolismMorbidity - Disease RateRegulationMacrophageCardiovascular DiseasesGene ExpressionIn VitroEventInflammatoryLow-Density LipoproteinsCaveolin 1
Grant awards (29)
Sterol regulation of immunometabolic responses in cardiometabolic diseases$787,267
R01 · FY2025 · HL · contact PI
Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease$757,122
R01 · FY2025 · HL · contact PI
Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease$773,997
R01 · FY2024 · HL · contact PI
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2023 · HL · contact PI
Role of lipid droplets in insulin resistance$450,882
R01 · FY2023 · DK · contact PI
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2022 · HL · contact PI
Role of lipid droplets in insulin resistance$450,882
R01 · FY2022 · DK · contact PI
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2021 · HL · contact PI
Role of lipid droplets in insulin resistance$450,882
R01 · FY2021 · DK · contact PI
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2020 · HL · contact PI
Aging and clonality in atherosclerosis$209,375
R21 · FY2020 · AG
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2019 · HL · contact PI
Aging and clonality in atherosclerosis$251,250
R21 · FY2019 · AG
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2018 · HL · contact PI
Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis$850,059
R35 · FY2017 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$430,451
R01 · FY2016 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$416,250
R01 · FY2016 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$410,006
R01 · FY2015 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$410,006
R01 · FY2015 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$378,398
R01 · FY2014 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$359,382
R01 · FY2014 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$242,232
R01 · FY2013 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$229,707
R01 · FY2013 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$172,513
R01 · FY2013 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$159,988
R01 · FY2013 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$422,500
R01 · FY2012 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$422,500
R01 · FY2012 · HL · contact PI
Role of microRNAs in lipid metabolism and cardiovascular disease$422,500
R01 · FY2011 · HL · contact PI
Caveolin-1 in Lipoprotein Metabolism and Atherosclerosis.$422,500
R01 · FY2011 · HL · contact PI